NIH Funds MBio $5.2M to Develop Influenza Test | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – MBio Diagnostics today said that it and its collaborators have received a five-year, $5.2 million award from the National Institutes of Health to develop a rapid and inexpensive test for influenza.

The goal of the grant, awarded under NIH's Partnerships for Biodefense program, is to fund development of a nucleic acid-based test that provides the accuracy of laboratory-based molecular tests, but which will be easy to use, inexpensive, and can provide results quickly.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.